Natera, Inc. (NTRA) intrinsic value & 10-year financials

Natera, Inc. (NTRA) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 30.3% a year to $2.3B, with an average return on invested capital of -100.2%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$393.44
Market cap
$53.8B
Revenue (FY2025)
$2.3B
Revenue growth (10-yr CAGR)
30.3%
ROIC (10-yr avg)
-100.2%
Free cash flow (FY2025)
$109.1M

NTRA 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $2.3B -$208.2M -$1.52 $109.1M -13.4% -38.1%
FY2024 $1.7B -$190.4M -$1.53 $69.2M -13.1% -45.3%
FY2023 $1.1B -$434.8M -$3.78 -$286.2M -41.2% -72.4%
FY2022 $820.2M -$547.8M -$5.57 -$479.2M -66.0% -66.0%
FY2021 $625.5M -$471.7M -$5.21 -$376.3M -74.8% -63.7%
FY2020 $391.0M -$229.7M -$2.84 -$202.1M -55.3% -53.9%
FY2019 $302.3M -$124.8M -$1.79 -$68.4M -38.5% -70.7%
FY2018 $257.7M -$128.2M -$2.22 -$74.5M -44.5% -363.7%
FY2017 $209.6M -$136.3M -$2.56 -$106.7M -63.9% -159.6%
FY2016 $212.5M -$95.8M -$1.86 -$97.0M -45.4% -68.5%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Natera, Inc. is a consistent compounder, expanding top-line revenue at 30.3% annually over the past decade.

Natera, Inc. has historically struggled to out-earn its cost of capital, averaging just -48.4% ROIC.

Natera, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Natera, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-50.49 per share.

NTRA stock: frequently asked questions

What is the intrinsic value of Natera, Inc. (NTRA) stock?

Graham's formula only works with positive earnings. Natera, Inc. reported diluted EPS of -$1.52 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

How fast has Natera, Inc. grown?

Revenue went from $212.5M in fiscal 2016 to $2.3B in fiscal 2025, a compound annual growth rate of 30.3%. Net income was -$208.2M in fiscal 2025.

Does Natera, Inc. generate free cash flow?

Natera, Inc. generated $109.1M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 2 of the last 10 reported years.

What is NTRA's return on invested capital?

Average ROIC over the last 10 fiscal years was -100.2%, and average return on equity was -194.6%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this NTRA data come from?

From Natera, Inc.'s annual 10-K filings on SEC EDGAR. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar medical laboratories stocks